SelectScience InterviewsDrug discovery > Target Discovery
Assay Miniaturization for High Throughput Compound Screening at AstraZeneca
16 Feb 2016Watch this video to learn how assay miniaturization is enhancing compound screening workflow at AstraZeneca. Helen Plant, a Senior Scientist at the global high throughput screening centre, describes how Corning’s Epic® system is facilitating screening automation and increasing the diversity of compounds screened in assays at AstraZeneca.